Geron (GERN) EBIT (2010 - 2026)

Geron has disclosed EBIT across 17 years of filings, most recently posting -$12.5 million for Q2 2026.

• In Q2 2026, EBIT changed 0.34% year-over-year to -$12.5 million; the TTM figure through Jun 2026 stood at -$51.8 million (up 33.14% YoY), while the FY2025 annual figure was -$68.6 million, up 60.52% from the prior year.
• EBIT came in at -$12.5 million for Q2 2026 at Geron, down from $158000.0 in the prior quarter.
• In the past five years, EBIT ranged from a high of $158000.0 in Q1 2026 to a low of -$69.3 million in Q2 2024.
• Average EBIT over 5 years is -$32.6 million, with a median of -$28.4 million recorded in 2022.
• Year-over-year, EBIT plunged 85.7% in 2023 and jumped 100.95% in 2026.
• Over 5 years, EBIT stood at -$42.0 million in 2022, then dropped by 29.41% to -$54.3 million in 2023, then surged by 63.07% to -$20.0 million in 2024, then declined by 27.38% to -$25.5 million in 2025, then jumped by 51.07% to -$12.5 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$12.5 million in Q2 2026, $158000.0 in Q1 2026, and -$25.5 million in Q4 2025.